Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients.
作者信息
Brito-Azevedo Anderson
机构信息
Liver Transplant Unit, São Lucas Hospital, Rio de Janeiro, RJ, Brazil; Liver Transplant Unit, Adventista Silvestre Hospital, Rio de Janeiro, RJ, Brazil.
出版信息
Int J Infect Dis. 2020 Oct;99:324. doi: 10.1016/j.ijid.2020.07.079. Epub 2020 Aug 6.
Abstract
摘要
相似文献
1
Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients.羟氯喹在新冠病毒病中的应用：重视统计学以关爱患者。
Int J Infect Dis. 2020 Oct;99:324. doi: 10.1016/j.ijid.2020.07.079. Epub 2020 Aug 6.
2
Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going.阿奇霉素与 SARS-CoV-2 感染：我们现在在哪里，以及我们将走向何方。
J Glob Antimicrob Resist. 2020 Sep;22:680-684. doi: 10.1016/j.jgar.2020.06.016. Epub 2020 Jul 1.
3
Hydroxychloroquine and azithromycin as a treatment of COVID-19.羟氯喹和阿奇霉素作为新型冠状病毒肺炎的一种治疗方法。
Intern Emerg Med. 2020 Aug;15(5):841-843. doi: 10.1007/s11739-020-02388-y. Epub 2020 May 30.
4
Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research.用于治疗新冠病毒病的羟氯喹——当疫情发展速度超过研究速度时
Int J Cardiol. 2020 Oct 1;316:285-286. doi: 10.1016/j.ijcard.2020.05.079. Epub 2020 May 29.
5
No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".没有证据表明用羟氯喹和阿奇霉素对新冠病毒疾病患者进行早期治疗有临床益处：对《用羟氯喹和阿奇霉素对新冠病毒疾病患者进行早期治疗：法国马赛1061例回顾性分析》的评论
Travel Med Infect Dis. 2020 Jul-Aug;36:101819. doi: 10.1016/j.tmaid.2020.101819. Epub 2020 Jul 3.
6
Hydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous?用于治疗COVID-19的羟氯喹啉-阿奇霉素——合理还是危险？
Travel Med Infect Dis. 2020 May-Jun;35:101764. doi: 10.1016/j.tmaid.2020.101764. Epub 2020 May 30.
7
Experience of short-term hydroxychloroquine and azithromycin in COVID-19 patients and effect on QTc trend.新冠病毒肺炎患者短期使用羟氯喹和阿奇霉素的经验及其对QTc趋势的影响
J Infect. 2020 Aug;81(2):e117-e119. doi: 10.1016/j.jinf.2020.05.058. Epub 2020 May 28.
8
Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation.羟氯喹、2019冠状病毒病与QT间期延长
JAMA Cardiol. 2020 Sep 1;5(9):986-987. doi: 10.1001/jamacardio.2020.1782.
9
Safe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center.在新型冠状病毒肺炎疫情背景下羟氯喹及其与阿奇霉素联合使用的安全性：比利时一家三级中心的临床经验
Travel Med Infect Dis. 2020 Jul-Aug;36:101788. doi: 10.1016/j.tmaid.2020.101788. Epub 2020 Jun 12.
10
QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.在新冠肺炎患者使用羟氯喹和/或阿奇霉素期间控制QT间期以预防尖端扭转型室速
Arq Bras Cardiol. 2020 Jun;114(6):1061-1066. doi: 10.36660/abc.20200389. Epub 2020 Jul 3.
引用本文的文献
1
A 21st Century Evil: Immunopathology and New Therapies of COVID-19.二十一世纪的罪恶：COVID-19 的免疫病理学和新疗法。
Front Immunol. 2020 Oct 27;11:562264. doi: 10.3389/fimmu.2020.562264. eCollection 2020.
本文引用的文献
1
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19.羟氯喹、阿奇霉素和联合治疗 COVID-19 住院患者。
Int J Infect Dis. 2020 Aug;97:396-403. doi: 10.1016/j.ijid.2020.06.099. Epub 2020 Jul 2.
2
Covid-19: Low dose steroid cuts death in ventilated patients by one third, trial finds.新冠疫情：试验发现，低剂量类固醇可将使用呼吸机患者的死亡率降低三分之一。
BMJ. 2020 Jun 16;369:m2422. doi: 10.1136/bmj.m2422.
Zotero 插件